SCHEMBL6289307

SCHEMBL6289307

Nc1ccc(Oc2cccc(Oc3cccc(Oc4cccc(Oc5cccc(Oc6ccc(N)cc6)c5)c4)c3)c2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 1.00
MAPT P10636 5/20 1.00
MEN1 O00255 4/20 1.00
KMT2A Q03164 4/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
MITF O75030 1/20 1.00
GAA P10253 1/20 1.00
GFER P55789 1/20 1.00
NLRP1 Q9C000 1/20 1.00
NOD2 Q9HC29 1/20 1.00
MAOA P21397 2/20 0.73
TDP1 Q9NUW8 2/20 0.70
CYP3A4 P08684 1/20 0.70
TSHR P16473 1/20 0.70
NPC1 O15118 2/20 0.69
RAB9A P51151 2/20 0.69
NLRP3 Q96P20 1/20 0.69
MAOB P27338 2/20 0.64
TEAD4 Q15561 1/20 0.56
FURIN P09958 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964017 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL562469 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL63594 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6290623 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1271678 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL4092959 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1270594 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL6290330 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL22289568 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL29948036 1.00 ALDH1A1 (1.00) ALDH1A1MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 ALDH1A1 902/4885MAPT 471/4885MEN1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.